EUVIMEDEUVIMED entdecken
Video/Audio

Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy

Yan Xu, Yanru Li, Jinfeng Rong, Ye Qiu

Journal of Visualized Experiments · 30.10.2026 · (236)

DOI: 10.3791/73732 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, online erschienen am 30.10.2026. Verfasst von Yan Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Second People's Hospital of Yibin. Hauptthemen laut MEDLINE: Oxaliplatin, Colorectal Neoplasms, Diabetic Neuropathies, Antineoplastic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) patients with comorbid diabetic peripheral neuropathy (DPN) face an increased risk of oxaliplatin-induced dose-limiting toxicity (DLT). This study aimed to develop a machine learning model to predict chemotherapy tolerance and investigate nonlinear feature associations within the predictive framework. We retrospectively analyzed 513 CRC patients with DPN. Five machine learning algorithms were developed and evaluated, and SHapley Additive exPlanations (SHAP) were used to explore feature associations. The XGBoost model demonstrated the highest discriminative performance in predicting DLT (AUC = 0.880), significantly outperforming logistic regression (p = 0.002). SHAP analysis showed that cumulative oxaliplatin dose, poor glycemic control (HbA1c > 8.0%), and systemic inflammation (NLR) were associated with increased model-predicted risk of DLT. Interaction analyses further identified nonlinear model-level associations between oxaliplatin exposure and metabolic and neurological features. The XGBoost model combined with SHAP explanations provides an exploratory framework for dynamic risk stratification during treatment. These findings represent associative predictive patterns and require prospective, external validation before clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinColorectal NeoplasmsDiabetic NeuropathiesAntineoplastic AgentsOrganoplatinum CompoundsHumansRetrospective StudiesBoosting Machine Learning AlgorithmsFemaleMaleMachine LearningMiddle Aged

Substanzen

OxaliplatinAntineoplastic AgentsOrganoplatinum Compounds

Autor:innen und Institutionen

  • Second People's Hospital of Yibin.
  • Second People's Hospital of Yibin; LiYanru01234@163.com.

Zitieren

APA

Xu, Y., Li, Y., Rong, J., & Qiu, Y. (2026). Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy. Journal of Visualized Experiments. https://doi.org/10.3791/73732

Vancouver

Xu Y, Li Y, Rong J, Qiu Y. Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy. Journal of Visualized Experiments. 2026. doi:10.3791/73732

BibTeX
@article{Xu2026,
  author = {Xu, Yan and Li, Yanru and Rong, Jinfeng and Qiu, Ye},
  title = {Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {236},
  doi = {10.3791/73732}
}
Kostenlos starten →